Using Nintendo Switch with therapy for brain injury recovery
Study on the Effectiveness of the Use of the Nintendo Switch Combined With Conventional Therapy in People With Acquired Brain Injury: A Pilot Study
This study is testing if using a Nintendo Switch during therapy can help adults with brain injuries recover better than just standard therapy alone.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 32 (estimated) |
| Ages | 30 Years and up |
| Sex | All |
| Sponsor | Universidad Rey Juan Carlos Academic / other |
| Locations | 1 site (Móstoles, Madrid) |
| Trial ID | NCT06285877 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of combining conventional therapy with virtual reality using the Nintendo Switch for adults with acquired brain injuries. Participants will be divided into two groups: one receiving standard therapy and the other receiving therapy enhanced with Nintendo Switch sessions over eight weeks. The study will measure improvements in postural control and cognitive capacity using various assessment tools. The goal is to enhance motivation and satisfaction in care for individuals undergoing rehabilitation.
Who should consider this trial
Good fit: Ideal candidates are adults over 30 years old who have suffered a mild to moderate acquired brain injury and are currently receiving conventional therapy.
Not a fit: Patients with severe cognitive impairment, aphasia, or other significant underlying health conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve rehabilitation outcomes and patient engagement for those recovering from acquired brain injuries.
How similar studies have performed: While the use of virtual reality in rehabilitation is gaining traction, this specific combination with Nintendo Switch is relatively novel and has not been extensively tested in similar studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult men and women, over 30 years of age who have suffered an acquired brain injury. * Mild or moderate cognitive impairment as measured by the MEC-Lobo test (score greater than 23/35). * Regularly attend some conventional therapy (neuropsychology, physiotherapy or occupational therapy). * Agree to participate voluntarily by signing the informed consent form. Exclusion Criteria: * Present severe cognitive impairment as measured by the MEC-Lobo test (less than 23/35). * Present aphasia of comprehension or expression. * Present associated neurodegenerative pathology. * Present any pathology underlying the acquired brain damage (diabetes, heart disease, COPD, etc.), heart disease, COPD, etc.). * Voluntarily refuse to participate in the study.
Where this trial is running
Móstoles, Madrid
- Universidad Rey Juan Carlos — Móstoles, Madrid, Spain (Recruiting)
Study contacts
- Principal investigator: Isabel Quirosa Galan, MsC — Universidad Rey Juan Carlos
- Study coordinator: Isabel Quirosa Galan, MsC
- Email: i.quirosa.2016@alumnos.urjc.es
- Phone: +34655551210
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.